G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters
The COVID-19 pandemic caused by SARS-CoV-2 has caused millions of infections and deaths worldwide. Limited treatment options and the threat from emerging variants underline the need for novel and widely accessible therapeutics. G-quadruplexes (G4s) are nucleic acid secondary structures known to affe...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1133123/full |
_version_ | 1797869502755504128 |
---|---|
author | Shuvra Shekhar Roy Shuvra Shekhar Roy Shalu Sharma Shalu Sharma Zaigham Abbas Rizvi Dipanjali Sinha Dipanjali Sinha Divya Gupta Mercy Rophina Mercy Rophina Paras Sehgal Paras Sehgal Srikanth Sadhu Manas Ranjan Tripathy Sweety Samal Souvik Maiti Souvik Maiti Souvik Maiti Vinod Scaria Vinod Scaria Sridhar Sivasubbu Sridhar Sivasubbu Amit Awasthi Krishnan H. Harshan Krishnan H. Harshan Sanjeev Jain Shantanu Chowdhury Shantanu Chowdhury |
author_facet | Shuvra Shekhar Roy Shuvra Shekhar Roy Shalu Sharma Shalu Sharma Zaigham Abbas Rizvi Dipanjali Sinha Dipanjali Sinha Divya Gupta Mercy Rophina Mercy Rophina Paras Sehgal Paras Sehgal Srikanth Sadhu Manas Ranjan Tripathy Sweety Samal Souvik Maiti Souvik Maiti Souvik Maiti Vinod Scaria Vinod Scaria Sridhar Sivasubbu Sridhar Sivasubbu Amit Awasthi Krishnan H. Harshan Krishnan H. Harshan Sanjeev Jain Shantanu Chowdhury Shantanu Chowdhury |
author_sort | Shuvra Shekhar Roy |
collection | DOAJ |
description | The COVID-19 pandemic caused by SARS-CoV-2 has caused millions of infections and deaths worldwide. Limited treatment options and the threat from emerging variants underline the need for novel and widely accessible therapeutics. G-quadruplexes (G4s) are nucleic acid secondary structures known to affect many cellular processes including viral replication and transcription. We identified heretofore not reported G4s with remarkably low mutation frequency across >5 million SARS-CoV-2 genomes. The G4 structure was targeted using FDA-approved drugs that can bind G4s - Chlorpromazine (CPZ) and Prochlorperazine (PCZ). We found significant inhibition in lung pathology and lung viral load of SARS-CoV-2 challenged hamsters when treated with CPZ or PCZ that was comparable to the widely used antiviral drug Remdesivir. In support, in vitro G4 binding, inhibition of reverse transcription from RNA isolated from COVID-infected humans, and attenuated viral replication and infectivity in Vero cell cultures were clear in case of both CPZ and PCZ. Apart from the wide accessibility of CPZ/PCZ, targeting relatively invariant nucleic acid structures poses an attractive strategy against viruses like SARS-CoV-2, which spread fast and accumulate mutations quickly. |
first_indexed | 2024-04-10T00:13:40Z |
format | Article |
id | doaj.art-be185dc57a37426ca40b3079c5373adf |
institution | Directory Open Access Journal |
issn | 2296-889X |
language | English |
last_indexed | 2024-04-10T00:13:40Z |
publishDate | 2023-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Molecular Biosciences |
spelling | doaj.art-be185dc57a37426ca40b3079c5373adf2023-03-16T07:22:14ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2023-03-011010.3389/fmolb.2023.11331231133123G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamstersShuvra Shekhar Roy0Shuvra Shekhar Roy1Shalu Sharma2Shalu Sharma3Zaigham Abbas Rizvi4Dipanjali Sinha5Dipanjali Sinha6Divya Gupta7Mercy Rophina8Mercy Rophina9Paras Sehgal10Paras Sehgal11Srikanth Sadhu12Manas Ranjan Tripathy13Sweety Samal14Souvik Maiti15Souvik Maiti16Souvik Maiti17Vinod Scaria18Vinod Scaria19Sridhar Sivasubbu20Sridhar Sivasubbu21Amit Awasthi22Krishnan H. Harshan23Krishnan H. Harshan24Sanjeev Jain25Shantanu Chowdhury26Shantanu Chowdhury27CSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaImmuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, Faridabad, 121001, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaCSIR-Centre for Cellular and Molecular Biology, Hyderabad, 500007, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaImmuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, Faridabad, 121001, IndiaImmuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, Faridabad, 121001, IndiaTranslational Health Science and Technology Institute, Faridabad, 411008, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaCSIR-National Chemical Laboratory, Pune, 121001, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaImmuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, Faridabad, 121001, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaCSIR-Centre for Cellular and Molecular Biology, Hyderabad, 500007, IndiaMolecular Genetics Laboratory, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, 560029, IndiaCSIR-Institute of Genomics & Integrative Biology, New Delhi, 110025, IndiaAcademy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, IndiaThe COVID-19 pandemic caused by SARS-CoV-2 has caused millions of infections and deaths worldwide. Limited treatment options and the threat from emerging variants underline the need for novel and widely accessible therapeutics. G-quadruplexes (G4s) are nucleic acid secondary structures known to affect many cellular processes including viral replication and transcription. We identified heretofore not reported G4s with remarkably low mutation frequency across >5 million SARS-CoV-2 genomes. The G4 structure was targeted using FDA-approved drugs that can bind G4s - Chlorpromazine (CPZ) and Prochlorperazine (PCZ). We found significant inhibition in lung pathology and lung viral load of SARS-CoV-2 challenged hamsters when treated with CPZ or PCZ that was comparable to the widely used antiviral drug Remdesivir. In support, in vitro G4 binding, inhibition of reverse transcription from RNA isolated from COVID-infected humans, and attenuated viral replication and infectivity in Vero cell cultures were clear in case of both CPZ and PCZ. Apart from the wide accessibility of CPZ/PCZ, targeting relatively invariant nucleic acid structures poses an attractive strategy against viruses like SARS-CoV-2, which spread fast and accumulate mutations quickly.https://www.frontiersin.org/articles/10.3389/fmolb.2023.1133123/fullRNA G-quadruplexFDA-approved drugsG-quadruplex binding drugshamster model of COVID-19Conserved motif |
spellingShingle | Shuvra Shekhar Roy Shuvra Shekhar Roy Shalu Sharma Shalu Sharma Zaigham Abbas Rizvi Dipanjali Sinha Dipanjali Sinha Divya Gupta Mercy Rophina Mercy Rophina Paras Sehgal Paras Sehgal Srikanth Sadhu Manas Ranjan Tripathy Sweety Samal Souvik Maiti Souvik Maiti Souvik Maiti Vinod Scaria Vinod Scaria Sridhar Sivasubbu Sridhar Sivasubbu Amit Awasthi Krishnan H. Harshan Krishnan H. Harshan Sanjeev Jain Shantanu Chowdhury Shantanu Chowdhury G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters Frontiers in Molecular Biosciences RNA G-quadruplex FDA-approved drugs G-quadruplex binding drugs hamster model of COVID-19 Conserved motif |
title | G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters |
title_full | G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters |
title_fullStr | G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters |
title_full_unstemmed | G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters |
title_short | G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters |
title_sort | g4 binding drugs chlorpromazine and prochlorperazine repurposed against covid 19 infection in hamsters |
topic | RNA G-quadruplex FDA-approved drugs G-quadruplex binding drugs hamster model of COVID-19 Conserved motif |
url | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1133123/full |
work_keys_str_mv | AT shuvrashekharroy g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT shuvrashekharroy g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT shalusharma g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT shalusharma g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT zaighamabbasrizvi g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT dipanjalisinha g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT dipanjalisinha g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT divyagupta g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT mercyrophina g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT mercyrophina g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT parassehgal g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT parassehgal g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT srikanthsadhu g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT manasranjantripathy g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT sweetysamal g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT souvikmaiti g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT souvikmaiti g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT souvikmaiti g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT vinodscaria g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT vinodscaria g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT sridharsivasubbu g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT sridharsivasubbu g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT amitawasthi g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT krishnanhharshan g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT krishnanhharshan g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT sanjeevjain g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT shantanuchowdhury g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters AT shantanuchowdhury g4bindingdrugschlorpromazineandprochlorperazinerepurposedagainstcovid19infectioninhamsters |